April 2021

Abstract

AACR Annual Meeting

April 2021

Abstract

AACR Annual Meeting

Immune checkpoint inhibitor therapy for metastatic colorectal cancer: real-world practice patterns and predictors of overall survival

Bari, S, Matejcic, M, Kim, R, Xie, H, Carballido, E, Sahin, I, Powers, B, Felder, S, Schmit, SL

April 2021

Abstract

AACR Annual Meeting

April 2021

Abstract

AACR Annual Meeting

Changes over time in real-world next-generation sequencing test use in patients with advanced non-small cell lung cancer

Swaminathan, A, Stergiopoulos, S, Snider, JW, Fisher, V, Castellanos, EH, Snow, T, Cho-Phan, C, Comment, L, Cunningham, R, McCusker, M

April 2021

Abstract

AACR Annual Meeting

Flatiron-authored

Comprehensive genomic profiling in breast cancer: patterns and results from a clinico-genomic database

Rody, A, Chaudhary, N, Craggs, C, Debiasi, M, Erb, G, Fisher, V, McCusker, M, Snow, T, Losada, MV, Luhn, P

April 2021

Abstract

AACR Annual Meeting

Flatiron-authored

Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2−metastatic breast cancer in US real-world clinical practice

DeMichele, A, Cristofanilli, M, Brufsky, A, Liu, X, Mardekian, J, McRoy, L, Layman, RM, Emir, B, Torres, M, Rugo, HS, Finn, RS

March 2021

Manuscript

Breast Cancer Research

March 2021

Manuscript

Cancer

Flatiron-authored

Concurrent cetuximab and nivolumab as a second-line or beyond treatment of patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results of phase I/II study

Chung, CH, Bonomi, M, Steuer, C, Li, J, Bhateja, P, Johnson, M, Masannat, J, Song, F, Hernandez-Prera, JC, Wenig, BM, Molena, H, Farinhas, JM, McMullen, CP, Wadsworth, JT, Patel, KB, Kish, JA, Muzaffar, J, Kirtane, K, Rocco, JW, Schell, MJ, Saba, NF

March 2021

Manuscript

Cancers

Characterization of a real-world response variable and comparison with RECIST-based response rates from clinical trials in advanced NSCLC

Ma, X, Bellomo, L, Magee, K, Bennette, CS, Tymejczyk, O, Samant, MK, Tucker, MG, Nussbaum, NC, Bowser, BE, Kraut, JS, Bourla, AB

March 2021

Manuscript

Advances in Therapy

Flatiron-authored

Real-world overall survival and time to therapy discontinuation of patients with mCRPC treated with second-generation novel hormonal therapies associated with tissue-based comprehensive genomic profiling

Graf, RP, Madison, RW, Gjoerup, O, Zhong, L, Morley, S, Chopra, S, Comment, L, Fisher, V, Li, G, MGregor, K, Schrock, AB, Tukachinsky, H, Snow, T, Cho-Phan, C, Swaminathan, A, Ross, JS, McCusker, M, Zurita, AJ, Venstrom, JM

February 2021

Abstract

ASCO GU Symposium

Flatiron-authored

Real-world clinical outcomes study of sequential novel antihormonal therapy or radium-223 treatment of metastatic castration-resistant prostate cancer that progressed after first-line NAH

Sartor, AO, George, DJ, Tombal, B, Higano, CS, Sternberg, CN, Miller, K, Jiao, X, Guo, H, Sandstrom, P, Verholen, F, Saad, F, Shore, ND

February 2021

Abstract

ASCO GU Symposium

February 2021

Abstract

ASCO GU Symposium

Real-world treatment patterns and sequencing for metastatic renal cell carcinoma: results from the Flatiron database

George, S, Faccone, J, Huo, S, Zhang, Y, Stwalley, B, Hamilton, M, Le, TK, Ejzykowicz, F

February 2021

Abstract

ASCO GU Symposium

February 2021

Abstract

ASCO GU Symposium

February 2021

Abstract

ASCO GU Symposium

February 2021

Abstract

ASCO GU Symposium

February 2021

Manuscript

European Journal of Haematology

February 2021

Manuscript

Advances in Therapy

February 2021

Manuscript

NPJ Digital Medicine

February 2021

Manuscript

Epidemiology

January 2021

Manuscript

Breast Cancer Research

RAS amplification as a negative predictor of benefit from anti-EGFR containing therapy regimens in metastatic colorectal cancer

Schrock, AB, Lee, JK, Sandhu, J, Madison, RW, Cho-Phan, C, Snider, JW, Castellanos, EH, Venstrom, JM, Fakih, M

January 2021

Manuscript

The Oncologist

Flatiron-authored

Real-world characterization of advanced non-small cell lung cancer in never smokers by actionable mutation status

Kerrigan, KC, Wang, X, Haaland, B, Adamson, BJS, Patel, SB, Puri, S, Akerley, WL

January 2021

Manuscript

Clinical Lung Cancer

Flatiron-authored

January 2021

Manuscript

JCO Clinical Cancer Informatics

January 2021

Manuscript

JAMA Open

January 2021

Manuscript

BMC Cancer

December 2020

Abstract

HTAi

Flatiron-authored

December 2020

Manuscript

Current Medical Research and Opinion

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

Redefining the prognostic significance of t(11,14) multiple myeloma

Giri, S, Costa, LJ, Godby, KN, Bhatia, S, Williams, G

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

A clinical practice comparison of patients with CLL/SLL with and without del(17p) receiving first-line treatment with ibrutinib

Hedrick, E, Mato, A, Sharman, J, Tang, B, Azmi, S, Pinilla-Ibarz, J, Yang, K, Stern, J, Huang, J

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

Treatment patterns and outcomes of multiple myeloma (MM) with chromosome translocation (11,14) in United States routine clinical practice

Atrash, S, Flahavan, EM, Xu, T, Ma, E, Karve, S, Hong, W, Jirau-Lucca, G, Nixon, M, Ailawadhi, S

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2020

Abstract

American Society of Hematology Annual Meeting

December 2020

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

November 2020

Manuscript

Journal of Nuclear Medicine

Flatiron-authored

Understanding the impact of assessment frequency on the study of adverse effects using oncology electronic health records

Liang, Q, Zhang, Q, Rosic, A, Bowser, B, Tharani, S, Brake, SD, Magee, K, Parrinello, CM, Baxi, SS

November 2020

Abstract

EU ISPOR

Flatiron-authored

November 2020

Abstract

EU ISPOR

Flatiron-authored

Prevalence of high tumor mutational burden and association with survival in patients with less common solid tumors

Shao, C, Li, G, Huang, L, Pruitt, SK, Castellanos, EH, Frampton, GM, Carson, KR, Snow, T, Singal, G, Fabrizio, D, Alexander, BM, Jin, FJ, Zhou, W

October 2020

Manuscript

JAMA Open

Flatiron-authored

October 2020

Manuscript

Journal of Comparative Effectiveness Research

Supporting optimal; value-based; and sustainable cancer care delivery

McAneny, B, Schwartzberg, L, Koh, W, Arrowsmith, E, Fugaro, A, Haydell, T, Hesketh, PJ, Pudusseri, A, Richey, S, Zarwan, C, Stein, R

October 2020

Manuscript

Journal of Clinical Pathways

Flatiron-authored